Janice Mehnert

6PUBLICATIONS
72CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Veterinary epidemiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2026
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.

|May 18, 2026
Focal Small Bowel FDG Uptake in Cancer Patients Undergoing PET/CT: Prevalence and Etiology.

|Oct 09, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Anne S Tsao, Zihe Song, Alan L Ho

|Apr 04, 2025
Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.

Allen Ye Fu, Kenneth Bernstein, Jeff Zhang

|Dec 03, 2024
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.

Srilatha Simhadri, Jillian N Carrick, Susan Murphy

|Jun 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.

Omid Hamid, Karl D Lewis, Amy Weise

Pageof 1

Frequent Collaborators

2 joint publications

Meredith McKean

2 joint publications

Kevin B Kim

1 joint publications

Anne S Tsao

1 joint publications

Alan L Ho